Intralymphatic GAD-alum Injection Modulates B Cell Response and Induces Follicular Helper T Cells and PD-1+ CD8+ T Cells in Patients With Recent-Onset Type 1 Diabetes
Antigen-specific immunotherapy is an appealing strategy to preserve beta-cell function in type 1 diabetes, although the approach has yet to meet its therapeutic endpoint. Direct administration of autoantigen into lymph nodes has emerged as an alternative administration route that can improve the eff...
Main Authors: | Hugo Barcenilla, Mikael Pihl, Jeanette Wahlberg, Johnny Ludvigsson, Rosaura Casas |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.797172/full |
Similar Items
-
Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
by: Sara Puente-Marin, et al.
Published: (2023-02-01) -
Expansion of extrafollicular B and T cell subsets in childhood-onset systemic lupus erythematosus
by: Ryan M. Baxter, et al.
Published: (2023-10-01) -
Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
by: Johnny Ludvigsson
Published: (2020-02-01) -
Variation of Immune Cell Responses in Humans Reveals Sex-Specific Coordinated Signaling Across Cell Types
by: Gabriela K. Fragiadakis, et al.
Published: (2022-03-01) -
Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV
by: Tongcui Ma, et al.
Published: (2022-07-01)